secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hepion Pharmaceuticals, Inc. (HEPA)
CIK:        0001583771
Form:       8-K
Filed at:   2026-04-22T23:59:59+00:00
Accession:  0001493152-26-018575
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud

Hepion Pharmaceuticals raises $700,000 in private placement of 17.5 million shares
--------------------------------------------------------------------------------

- Hepion entered securities purchase agreements with accredited investors on April 21, 2026, selling 17,500,000 shares at $0.04 per share.
- Gross proceeds from the private placement were $700,000, and the offering closed on the same date.
- The shares were issued in reliance on exemptions under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D.
- Gary Stetz, Interim CEO, signed the 8-K filing on behalf of Hepion Pharmaceuticals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583771/000149315226018575/0001493152-26-018575-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583771/000149315226018575/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-018575

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer